- Home
- ITOS vs POLE Comparison
ITOS vs POLE Comparison
Compare ITOS & POLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- POLE
- Stock Information
- Founded
- ITOS 2011
- POLE 2024
- Country
- ITOS United States
- POLE United States
- Employees
- ITOS N/A
- POLE N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- POLE
- Sector
- ITOS Health Care
- POLE
- Exchange
- ITOS Nasdaq
- POLE NYSE
- Market Cap
- ITOS 271.1M
- POLE 294.2M
- IPO Year
- ITOS 2020
- POLE 2024
- Fundamental
- Price
- ITOS $7.41
- POLE $9.98
- Analyst Decision
- ITOS Strong Buy
- POLE
- Analyst Count
- ITOS 3
- POLE 0
- Target Price
- ITOS $21.33
- POLE N/A
- AVG Volume (30 Days)
- ITOS 512.7K
- POLE 3.5K
- Earning Date
- ITOS 11-12-2024
- POLE 01-01-0001
- Dividend Yield
- ITOS N/A
- POLE N/A
- EPS Growth
- ITOS N/A
- POLE N/A
- EPS
- ITOS N/A
- POLE N/A
- Revenue
- ITOS $35,000,000.00
- POLE N/A
- Revenue This Year
- ITOS $271.18
- POLE N/A
- Revenue Next Year
- ITOS N/A
- POLE N/A
- P/E Ratio
- ITOS N/A
- POLE N/A
- Revenue Growth
- ITOS N/A
- POLE N/A
- 52 Week Low
- ITOS $7.09
- POLE $9.94
- 52 Week High
- ITOS $18.75
- POLE $11.16
- Technical
- Relative Strength Index (RSI)
- ITOS 36.39
- POLE N/A
- Support Level
- ITOS $7.09
- POLE N/A
- Resistance Level
- ITOS $7.53
- POLE N/A
- Average True Range (ATR)
- ITOS 0.37
- POLE 0.00
- MACD
- ITOS -0.02
- POLE 0.00
- Stochastic Oscillator
- ITOS 21.28
- POLE 0.00
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About POLE ANDRETTI ACQUISITION CORP. II
Andretti Acquisition Corp II is a blank check company.